Projected Income Statement: Exosens

Forecast Balance Sheet: Exosens

Forecast Balance Sheet - Exosens
Fiscal Period: December 2023 2024 2025 2026 2027 2028
Net Debt 1 - 144 198 160 90.8 16.1
Change - - 37.5% -19.07% -43.25% -82.27%
Announcement Date 23/05/24 03/03/25 23/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Exosens

Fiscal Period: December 2024 2025 2026 2027 2028
CAPEX 1 41.3 50.1 67.46 67.34 68.57
Change - 21.31% 34.65% -0.17% 1.82%
Free Cash Flow (FCF) 1 55.4 57.3 61.8 85.14 110.7
Change - 3.43% 7.85% 37.77% 29.98%
Announcement Date 03/03/25 23/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Exosens

Fiscal Period: December 2023 2024 2025 2026 2027 2028

Profitability

      
EBITDA Margin (%) - 30.07% 32.38% 32.56% 33.26% 34.12%
EBIT Margin (%) - 24.18% 27.25% 27.16% 28.02% 29.54%
EBT Margin (%) - 10.61% 18.84% 18.12% 23.77% 25.01%
Net margin (%) - 7.79% 9.12% 14.43% 17.91% 18.8%
FCF margin (%) - 14.06% 12.24% 10.93% 13.26% 15.35%
FCF / Net Income (%) - 180.46% 134.19% 75.77% 74.03% 81.67%

Profitability

      
ROA - 4.9% 9.36% 9.39% 11.46% 12.13%
ROE - 11.72% 18.49% 19.41% 21.35% 21.12%

Financial Health

      
Leverage (Debt/EBITDA) - 1.22x 1.3x 0.87x 0.43x 0.07x
Debt / Free cash flow - 2.6x 3.45x 2.59x 1.07x 0.15x

Capital Intensity

      
CAPEX / Current Assets (%) - 10.48% 10.7% 11.93% 10.49% 9.51%
CAPEX / EBITDA (%) - 34.85% 33.05% 36.64% 31.54% 27.87%
CAPEX / FCF (%) - 74.55% 87.43% 109.16% 79.1% 61.96%

Items per share

      
Cash flow per share 1 - 2.308 2.117 2.523 3.115 3.565
Change - - -8.28% 19.19% 23.46% 14.42%
Dividend per Share 1 - 0.1 0.3 0.3673 0.5237 0.6346
Change - - 200% 22.42% 42.6% 21.18%
Book Value Per Share 1 - 8.128 8.792 10.11 11.92 14.02
Change - - 8.17% 15% 17.92% 17.61%
EPS 1 0.1 0.61 0.84 1.746 2.344 2.731
Change - 510% 37.7% 107.87% 34.27% 16.47%
Nbr of stocks (in thousands) - 50,783 50,762 50,911 50,911 50,911
Announcement Date 23/05/24 03/03/25 23/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 29.8x 22.2x
PBR 5.14x 4.36x
EV / Sales 4.96x 4.26x
Yield 0.71% 1.01%

EPS & Dividend

EPS & Dividend - Exosens


Y-o-Y evolution of P/E

Valuation ratios - P/E - Exosens
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Exosens
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Exosens
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
51.95EUR
Average target price
69.85EUR
Spread / Average Target
+34.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Exosens